S&P 500
(-0.06%) 5 465.91 points
Dow Jones
(0.09%) 39 149 points
Nasdaq
(0.15%) 17 744 points
Oil
(-0.05%) $80.79
Gas
(-5.04%) $2.62
Gold
(-0.87%) $2 310.50
Silver
(-0.29%) $28.79
Platinum
(3.19%) $1 017.90
USD/EUR
(0.35%) $0.937
USD/NOK
(0.78%) $10.69
USD/GBP
(0.53%) $0.792
USD/RUB
(-0.28%) $87.25

Sanntidsoppdatering for Marinus Pharmaceuticals [MRNS]

Børs: NASDAQ Sektor: Healthcare Industri: Biotechnology
Sist oppdatert26 jun 2024 @ 21:04

-6.62% $ 1.270

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 21:04):
Our systems believe the stock currently is undervalued by 0.01% compare to its pairs and should correct upwards.

Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders...

Stats
Dagens volum 529 676
Gjennomsnittsvolum 2.27M
Markedsverdi 69.76M
EPS $-0.680 ( Q1 | 2024-05-08 )
Neste inntjeningsdato ( $-0.590 ) 2024-08-08
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.480
(Sector) 42.63
(Industry) 24.32
ATR14 $0.00500 (0.39%)
AADI -8.24%
ABCL 1.10%
ABCM 0.04%
ABEO -3.32%
ABIO -1.68%
ABOS 4.23%
ABSI 4.08%
ABUS -0.82%
ABVX -3.00%
ACAD -0.38%
ACER -17.95%
ACET -8.99%
ACGN 1.29%
ACHL -2.48%
ACHV 4.11%
ACIU -1.25%
ACLX -0.44%
ACRV -5.28%
ACST -1.63%
ACXP 3.92%
ADAG 6.07%
ADAP -3.42%
ADGI 0.87%
ADIL -4.07%
ADMA -2.09%
ADPT 0.74%
ADTX -2.78%
ADVM 1.16%
ADXN -1.60%
AEON -2.80%
AEZS -2.49%
AFMD -2.97%
AGEN -3.83%
AGIO -2.17%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA 4.47%
AKRO -2.53%
AKTX 0.35%
AKUS 0.00%
ALBO 0.00%
ALDX -2.25%
ALEC -0.11%
ALGS -1.52%
ALKS 1.74%
ALLK -11.44%
ALLO -3.97%
ALLR -0.82%
ALNA 3.16%
ALNY 2.28%
ALPN 0.02%
ALPX 0.00%
ALRN -1.67%
ALT -14.24%
ALVR -0.66%
ALXN 0.00%
ALXO -13.55%
ALZN 4.02%
AMRN -2.75%
AMTI -3.13%
ANAB 1.01%
ANEB 6.06%
ANGN 0.00%
ANIX -3.04%
ANL -0.14%
ANNX 2.40%
ANPC -3.15%
APGE 0.59%
APGN 8.48%
APGNW 30.65%
APLM -5.90%
APLS 0.87%
APLT -1.13%
APM 1.26%
APOP 0.38%
APRE 0.84%
APTO 0.62%
APTX 3.17%
APVO 0.93%
ARAV -13.39%
ARCT -6.43%
ARDS -12.13%
ARDX 0.58%
ARGX -0.60%
ARNA 0.00%
ARPO -0.90%
ARQT -3.28%
ARTL -2.50%
ARTLW 0.00%
ARVN 7.89%
ARWR -1.86%
ASLN -3.44%
ASMB -6.49%
ASND -2.13%
ATAI -4.44%
ATHA 6.89%
ATHE 0.56%
ATHX -33.50%
ATNF 0.99%
ATOS 4.85%
ATRA -3.60%
ATXI -2.78%
ATXS -0.94%
AUPH -1.17%
AURA 4.11%
AUTL -3.30%
AVBP -5.16%
AVEO 0.00%
AVIR -2.19%
AVRO -1.41%
AVTE -1.03%
AVTX -3.74%
AVXL -5.06%
AXLA 0.00%
AXSM -1.47%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 1.78%
BCAB -5.23%
BCDA -3.75%
BCDAW -41.77%
BCEL 0.00%
BCLI 5.82%
BCRX 1.81%
BCTX 12.37%
BCTXW 13.02%
BCYC 1.10%
BDRX -4.01%
BDTX -0.21%
BEAM 2.60%
BFRA -2.91%
BGNE -2.25%
BIOR -4.69%
BIVI 2.76%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -2.78%
BLTE -1.20%
BLU 0.03%
BLUE -2.38%
BMEA -14.39%
BMRN 0.55%
BNOX 6.15%
BNTC -3.06%
BNTX -1.78%
BOLD -9.27%
BOLT -0.05%
BPMC -1.76%
BPTH -1.43%
BPTS -13.47%
BRNS -0.37%
BRTX -4.25%
BTAI 11.82%
BTTX 20.00%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 3.39%
CABA 1.66%
CADL 0.71%
CALA 0.00%
CALC -9.65%
CALT -1.59%
CAPR -0.86%
CARA -3.23%
CARM 6.96%
CASI 3.86%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS 0.56%
CCCC -2.65%
CCXI 0.00%
CDAK 0.00%
CDIO -2.99%
CDIOW 24.00%
CDMO -1.55%
CDMOP 0.04%
CDT -1.68%
CDTTW -39.60%
CDTX -6.44%
CDXC 6.56%
CDXS 8.46%
CELC -3.82%
CELU 1.33%
CELUW 11.80%
CERC -1.68%
CERE -1.61%
CERO -6.66%
CEROW -10.18%
CFRX -27.95%
CGEM -0.55%
CGEN -3.31%
CGON -1.47%
CGTX -3.98%
CHMA -6.00%
CHRS 4.13%
CINC 0.00%
CING 2.22%
CINGW 34.95%
CKPT -1.91%
CLBS -16.75%
CLDX -0.98%
CLGN 0.00%
CLLS -3.11%
CLNN -2.72%
CLNNW 0.00%
CLRB 6.67%
CLSD -2.40%
CLSN -0.68%
CLVS 0.00%
CMMB -3.89%
CMND 4.03%
CMPI 0.00%
CMPX 0.00%
CMRA 0.00%
CMRAW 33.33%
CMRX -4.38%
CNCE 0.00%
CNSP -35.21%
CNST 0.00%
CNTA 0.56%
CNTB -0.75%
CNTX -7.31%
COCP -2.00%
COEPW 32.45%
COGT -2.40%
CORT 2.63%
COYA 1.16%
CPRX -1.91%
CRBP -0.83%
CRBU -7.10%
CRDF 0.66%
CRGX -0.67%
CRIS -1.59%
CRNX -5.95%
CRSP 0.35%
CRTX 2.63%
CRVO -3.95%
CRVS 0.28%
CSBR -0.19%
CTCX -1.59%
CTIC 0.06%
CTMX -4.13%
CTNM 1.98%
CTXR -1.48%
CUE -3.78%
CVAC -7.20%
CVKD -2.34%
CWBR 2.80%
CYAD -12.96%
CYCC 8.49%
CYCCP 5.28%
CYCN 7.81%
CYT -2.27%
CYTK -2.78%
CYTO 0.00%
DARE 2.94%
DAWN -0.90%
DBTX -0.81%
DBVT 4.17%
DFFN 10.28%
DICE 0.06%
DMAC 29.14%
DNLI -2.30%
DNTH -6.08%
DOMH 1.06%
DRMA -2.57%
DRMAW -1.25%
DRNA 0.00%
DRTS 0.46%
DRTSW 0.00%
DRUG 1.43%
DSGN -2.42%
DTIL 0.63%
DYAI 9.68%
EARS -1.77%
EDIT -3.12%
EDSA 4.09%
EFTR 4.82%
EFTRW -51.85%
EIGR -9.21%
ELAB -3.01%
ELDN 8.40%
ELEV -2.49%
ELOX 10.77%
ELTX -5.15%
ELVN -1.26%
ELYM 6.08%
ENGN 0.86%
ENGNW 0.00%
ENLV 0.00%
ENOB 1.79%
ENSC 6.53%
ENTA -0.73%
ENTO -4.97%
ENTX -1.34%
ENVB 4.81%
EPIX -0.72%
EPRX -1.92%
EPZM 0.00%
EQ -0.90%
EQRX -2.09%
EQRXW 0.00%
ERAS 1.20%
ERNA -2.78%
ERYP 1.30%
ESLA 4.30%
ESLAW 16.64%
ETNB -4.70%
ETON 2.90%
ETTX 0.00%
EVAX -0.71%
EVGN 5.02%
EVLO 0.00%
EWTX -0.63%
EXAI -0.94%
EXEL 0.52%
EYEG -0.69%
EYEN 0.02%
EYPT 1.09%
FATE -11.96%
FBIO 0.00%
FBIOP 0.87%
FBLG -6.53%
FBRX -0.02%
FDMT -5.57%
FENC -2.52%
FGEN -10.21%
FHTX 8.21%
FIXX 0.77%
FMTX 0.00%
FNCH 0.00%
FOLD -1.57%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE 1.51%
FULC 1.25%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -0.45%
GANX -3.08%
GBIO -2.12%
GBT 0.01%
GDTC 0.50%
GERN -2.43%
GHRS -3.72%
GLMD -4.09%
GLPG -1.68%
GLSI 5.01%
GLTO -3.31%
GLUE -3.69%
GLYC -11.89%
GMAB -0.47%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -2.34%
GNLX -4.86%
GNPX -3.43%
GNTA 3.94%
GOSS -9.45%
GOVX -1.36%
GOVXW 10.89%
GPCR -6.86%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -0.44%
GRTX -1.66%
GTHX 1.36%
GUTS 0.35%
GXGXW 41.67%
GYRE -4.99%
HALO -1.65%
HARP 0.09%
HCWB -6.13%
HEPA -3.50%
HGEN -84.62%
HILS 5.66%
HLVX -1.30%
HOOK 1.97%
HOTH -1.65%
HOWL 0.85%
HRMY 3.62%
HRTX 8.03%
HSTO 0.00%
HUMA 1.32%
HUMAW -6.26%
IBRX -6.61%
ICCC -3.10%
ICPT 0.21%
ICU 15.67%
ICUCW 10.23%
ICVX -0.91%
IDRA -23.04%
IDYA -3.32%
IFRX -2.78%
IGMS -1.61%
IKNA -1.19%
IKT -9.93%
IMAB 0.00%
IMCR -3.36%
IMGN 0.02%
IMGO 0.00%
IMMP 5.13%
IMMX -6.90%
IMNM 3.64%
IMNN 0.89%
IMPL -27.27%
IMRA 15.96%
IMRN -0.40%
IMRX -3.15%
IMTX -1.33%
IMTXW 6.00%
IMUX 2.31%
IMV 0.00%
IMVT -3.59%
INAB -0.72%
INBX -2.92%
INCY -2.25%
INDP 6.85%
INFI -52.38%
INKT 1.69%
INM 3.32%
INMB 4.35%
INO 2.99%
INSM -1.12%
INTS -1.96%
INVA 0.46%
INZY 1.72%
IOBT -10.24%
IONS 1.17%
IOVA -2.72%
IPA 3.00%
IPHA 5.08%
IPSC -2.73%
IRON -2.67%
ISEE 0.38%
ITOS 1.98%
ITRM 2.33%
IVA 6.96%
IVVD -0.82%
JAGX 1.05%
JANX -4.99%
JAZZ -1.05%
JNCE 0.00%
JSPR -2.07%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -2.45%
KALV -3.12%
KDNY 0.22%
KMPH -0.34%
KNSA -2.03%
KNTE -0.38%
KOD -8.10%
KPRX -4.08%
KPTI -8.42%
KRBP -10.00%
KRON 1.58%
KROS -0.72%
KRRO -2.42%
KRTX 0.03%
KRYS 0.19%
KTRA 14.78%
KTTA -0.65%
KTTAW 0.92%
KURA 0.88%
KYMR -3.37%
KYTX -4.13%
KZIA 2.36%
KZR -1.48%
LABP 0.57%
LBPH -0.32%
LBPS 0.00%
LBPSW 14.81%
LEGN 0.78%
LENZ -2.88%
LEXX -1.54%
LEXXW -14.63%
LGND -1.21%
LGNDV 0.00%
LGVN -10.64%
LIAN -8.28%
LIFE 2.70%
LIPO -5.28%
LIXT -9.76%
LIXTW 46.21%
LJPC -0.32%
LMNL 0.12%
LOGC 0.70%
LPCN -3.68%
LPTX -2.75%
LQDA -0.16%
LRMR 0.21%
LSTA -1.68%
LTRN 5.74%
LUMO 1.79%
LVTX -4.12%
LXEO -8.68%
LXRX -2.06%
LYEL -35.54%
LYRA 4.03%
MACK 0.10%
MBIO -11.00%
MBRX -1.43%
MCRB 2.60%
MDGL -2.16%
MDNA -13.16%
MDWD 3.46%
MDXG -1.69%
MEIP 0.00%
MESO -1.93%
MGNX -5.24%
MGTA -7.74%
MGTX -0.71%
MGX 2.14%
MIRM 0.33%
MIRO 0.59%
MIST 3.08%
MITO 0.00%
MLEC -5.84%
MLECW 2.31%
MLND -5.36%
MLTX -0.03%
MLYS -6.49%
MNKD -0.76%
MNMD 3.04%
MNOV -1.06%
MNPR -8.54%
MOLN 2.20%
MOR 0.42%
MORF -3.05%
MREO -0.43%
MRKR -0.43%
MRNA -9.25%
MRNS -6.62%
MRSN -2.86%
MRTX -0.17%
MRUS -0.25%
MRVI -0.07%
MTCR -1.29%
MTEM 6.93%
MTP -18.50%
MURA -4.02%
MYMD 1.08%
NAMS -0.56%
NAMSW -0.42%
NAUT 1.11%
NBRV 0.71%
NBSE -1.56%
NBTX 8.40%
NCNA 0.36%
NERV -1.58%
NEXI -0.74%
NGM -1.28%
NGNE 3.31%
NKGN 10.91%
NKGNW -20.00%
NKTR 3.76%
NKTX -3.52%
NLSP 3.53%
NLSPW 26.67%
NMRA -1.94%
NMTR -42.97%
NOVN -24.84%
NRBO 14.44%
NRIX -0.70%
NRSN -2.74%
NRSNW 0.00%
NRXP -7.43%
NRXPW 18.33%
NRXS -1.20%
NTBL 2.62%
NTEC -12.45%
NTHI 0.00%
NTLA -5.29%
NTRBW -31.07%
NUVL -1.41%
NVAX -6.89%
NVCT -8.24%
NVIV -34.28%
NXTC -5.29%
NYMX -0.05%
OABI 2.90%
OABIW -10.06%
OBIO 1.90%
OBSV 0.00%
OCEA -2.82%
OCGN 8.47%
OCS -1.00%
OCUL 0.76%
OCUP 1.31%
ODT -4.27%
OKYO 1.72%
OLMA -5.37%
OMER -2.57%
OMGA -1.66%
ONCO 5.89%
ONCR -3.08%
ONCS 31.87%
ONCT -2.35%
ONCY 2.97%
ONTX -0.47%
ONVO 1.33%
OPNT 0.00%
OPT -4.00%
ORGS -0.69%
ORIC -3.56%
ORMP 16.96%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -1.80%
OVID 0.30%
OYST 0.00%
PALI -0.22%
PASG 0.00%
PBLA -7.50%
PBM -4.81%
PBYI 3.72%
PCSA -0.25%
PCVX -0.14%
PDSB -6.81%
PEPG 1.37%
PGEN -7.19%
PHAR 2.19%
PHAS 0.00%
PHAT -0.87%
PHIO -3.55%
PHIOW 36.47%
PHVS -5.83%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -2.38%
PLUR 7.39%
PMN -5.55%
PMVP -2.98%
PNT 0.16%
PPBT -6.87%
PRAX 6.99%
PRDS 0.93%
PRLD -3.43%
PROG -3.47%
PROK -0.67%
PRQR 1.20%
PRTA -2.89%
PRTC 0.62%
PRTG 0.54%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -12.80%
PSTX -3.49%
PTCT -0.74%
PTE -0.82%
PTGX -1.12%
PTIXW -48.41%
PULM 1.56%
PXMD 4.76%
PYPD 1.71%
PYXS 3.27%
QLGN -2.78%
QNCX 5.70%
QNRX -0.08%
QSI -32.15%
QSIAW -24.94%
QTTB 1.83%
QURE -1.12%
RAIN -1.63%
RANI 4.81%
RAPT -2.27%
RARE 2.11%
RCKT -10.06%
REGN -0.39%
RENB -2.80%
REPL -2.44%
RETA 0.02%
REUN -0.89%
REVB -1.40%
REVBU 3.46%
REVBW 5.00%
RGLS -5.85%
RGNX -6.74%
RIGL -6.24%
RLAY -5.04%
RLMD 0.00%
RLYB -4.36%
RNA 1.90%
RNAC -0.46%
RNAZ -0.65%
RNXT 1.79%
ROIV -1.94%
ROIVW 4.56%
RPHM -1.86%
RPRX -0.69%
RPTX -0.88%
RUBY 2.70%
RVLP -32.05%
RVMD -0.86%
RVMDW -29.90%
RVNC -0.42%
RVPH -0.79%
RVPHW -5.28%
RXDX 0.09%
RXRX -6.24%
RYTM -6.26%
RYZB 0.02%
RZLT 1.68%
SABS -1.37%
SABSW -11.81%
SAGE 0.09%
SANA -3.14%
SAVA -2.28%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 2.59%
SCPH 9.60%
SCPS 0.00%
SEEL -4.94%
SEER 0.00%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -1.41%
SGMT -5.32%
SGTX -2.56%
SIOX 22.63%
SLDB -3.35%
SLGL 5.23%
SLN -7.24%
SLNO 0.73%
SLRX -0.81%
SLS -2.56%
SMMT -3.12%
SNDX 2.92%
SNGX 2.08%
SNPX 0.23%
SONN -2.15%
SPPI -0.49%
SPRB -1.07%
SPRC -4.25%
SPRO 0.75%
SRNE 0.00%
SRPT -1.21%
SRRA 0.00%
SRRK -2.23%
SRZN -2.45%
STAB 0.00%
STOK -7.24%
STRO -3.85%
STSA 0.00%
STTK 6.62%
SURF -0.93%
SVRA -1.71%
SWTX -0.36%
SYBX 1.29%
SYRS -2.24%
TALS -0.73%
TARA -7.38%
TARS -2.50%
TBPH 0.71%
TCBP 9.58%
TCDA 0.00%
TCON -1.00%
TCRR 0.00%
TCRT -1.75%
TCRX 3.55%
TECH -0.86%
TENX -0.32%
TERN -8.14%
TFFP -7.61%
TGTX -6.98%
THRX 0.12%
TIL -1.09%
TLC 0.00%
TLSA -5.28%
TNGX -3.24%
TNXP -7.60%
TNYA -4.38%
TPST 5.34%
TRDA -4.77%
TRVI 2.68%
TRVN 0.68%
TSHA -18.86%
TSVT -4.26%
TTNP -6.05%
TVTX 3.14%
TYRA -6.83%
UBX -2.13%
UNCY -4.88%
URGN 2.21%
UTHR -0.19%
VACC 11.36%
VALN -6.70%
VAXX 106.25%
VBIV 0.91%
VBLT -8.77%
VCEL 0.98%
VCNX 8.64%
VCYT -0.97%
VERA -5.05%
VERU 2.59%
VERV -2.87%
VIGL -1.08%
VINC 2.93%
VIR -1.00%
VIRI -5.66%
VIRX 3.98%
VKTX -1.69%
VLON -13.04%
VNDA -4.07%
VOR -6.05%
VRCA 0.50%
VRDN -4.08%
VRNA -1.70%
VRPX 1.02%
VRTX 0.08%
VSTM 3.91%
VTGN -1.20%
VTVT 0.39%
VTYX -3.14%
VXRT -1.91%
VYGR -0.89%
VYNE -6.36%
VYNT 7.78%
WINT -2.72%
WVE -8.69%
XBIO 1.03%
XBIT 6.67%
XCUR 3.13%
XENE -1.71%
XERS 4.52%
XFOR 4.69%
XLO 4.42%
XLRN 0.00%
XNCR 0.26%
XOMA -8.67%
XOMAO -0.45%
XOMAP -0.82%
XRTX -7.96%
YMAB -1.71%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -3.73%
ZNTL -1.31%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-18 Silverstein Christine Berni Buy 2 300 Common Stock
2024-06-18 Silverstein Christine Berni Buy 10 450 Stock Option (Right to Buy)
2024-06-18 Noonberg Sarah B. Buy 2 300 Common Stock
2024-06-18 Noonberg Sarah B. Buy 10 450 Stock Option (Right to Buy)
2024-06-18 Mayleben Timothy M Buy 2 300 Common Stock
INSIDER POWER
92.42
Last 98 transactions
Buy: 2 862 017 | Sell: 91 369
Korrelasjon (AI algo v.1.1b): Undervalued: 0.01% $1.270 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: -0.26 (neutral)
Kort: 0.39 (neutral)
Signal:(40.951) Neutral

Marinus Pharmaceuticals Korrelasjon

10 Mest positive korrelasjoner
MBIO0.955
ALLR0.947
ZD0.938
APVO0.936
PERI0.935
HOFT0.933
ISSC0.929
MPAA0.927
POAI0.925
INVE0.921
10 Mest negative korrelasjoner
GRIN-0.964
ABIO-0.948
CSTE-0.945
GALT-0.941
NKTR-0.935
GAIA-0.935
SLAM-0.929
AMRK-0.928
PPTA-0.927
SGRP-0.927

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Marinus Pharmaceuticals Korrelasjon - Valuta/Råvare

The country flag -0.33
( neutral )
The country flag -0.12
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.11
( neutral )

Marinus Pharmaceuticals Økonomi

Annual 2023
Omsetning: $30.99M
Bruttogevinst: $28.50M (91.98 %)
EPS: $-2.63
FY 2023
Omsetning: $30.99M
Bruttogevinst: $28.50M (91.98 %)
EPS: $-2.63
FY 2022
Omsetning: $25.48M
Bruttogevinst: $25.14M (98.67 %)
EPS: $-0.510
FY 2021
Omsetning: $15.35M
Bruttogevinst: $13.87M (90.37 %)
EPS: $-2.69

Financial Reports:

No articles found.

Marinus Pharmaceuticals Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Marinus Pharmaceuticals

Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company's ZTALMY product candidate acts at synaptic and extrasynaptic GABAA receptors, a target for its anti-seizure, antidepressant, and anxiolytic potential. It is developing ganaxolone for treating genetic epilepsy disorders, such as PCDH19-related epilepsy, tuberous sclerosis complex, depressive disorders, and Lennox-Gestaut Syndrome. Marinus Pharmaceuticals, Inc. has license agreement with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc.; and collaboration agreement with Orion Corporation. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.

Total Execution Time: 2.4898021221161 seconds
Number of API calls: 3
Number of DB calls: 9